Completed NA INTERVENTIONAL 2-arm NCT02015403

To Compare The Efficacy Of N -Acetylcysteine and Standard Therapy Versus Standard Therapy In The Prevention Of Ischemic Hepatitis And Survival Post Upper GI Bleed

TO COMPARE THE EFFICACY OF N -ACETYLCYSTEINE AND STANDARD THERAPY VERSUS STANDARD THERAPY IN THE PREVENTION OF ISCHEMIC HEPATITIS AND SURVIVAL POST UPPER GI BLEED

Sponsor: Institute of Liver and Biliary Sciences, India

Conditions Ischemic Hepatitis

Interventions Standard Care (in control arm) Standard Care + NAC (N -ACETYLCYSTEINE)

Updated 6 times since 2017 Last updated: Sep 11, 2019 Started: Dec 31, 2013 Primary completion: May 31, 2015 Completion: May 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Ischemic Hepatitis and is currently completed. Institute of Liver and Biliary Sciences, India leads this study, which shows 6 recorded versions since 2013 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Oct 2019 — Jan 2021 [monthly]

Completed NA
Jun 2018 — Oct 2019 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Dec 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Institute of Liver and Biliary Sciences, India

Data source: Institute of Liver and Biliary Sciences, India

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New Delhi, India